CD70 and neoplasm: Furthermore, it has been demonstrated by others [160–162] that DCs electroporated with mRNA encoding CD40 ligand, CD70, and constitutively active toll-like receptor 4, so-called TriMix DCs, display increased potential for the induction and amplification of tumor-specific responses in patients with advanced melanoma.